Selected article for: "acute cardiac injury and clinical outcome"
Author: Alwaqfi, Nizar R.; Ibrahim, Khalid S.
Title: COVID-19: an update and cardiac involvement
  • Cord-id: xhfd183p
  • Document date: 2020_9_9
    • ID: xhfd183p
    Snippet: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects host cells through angiotensin converting enzyme 2 receptors, leading to coronavirus disease (COVID-19)-related pneumonia, and also causing acute cardiac injury and chronic damage to the cardiovascular system. The purpose of this review is primarily reviewing the COVID-19 disease, including pathogen, clinical features, diagnosis, and treatment with particular attention to cardiovascular involvement based on the current evidence
    Document: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects host cells through angiotensin converting enzyme 2 receptors, leading to coronavirus disease (COVID-19)-related pneumonia, and also causing acute cardiac injury and chronic damage to the cardiovascular system. The purpose of this review is primarily reviewing the COVID-19 disease, including pathogen, clinical features, diagnosis, and treatment with particular attention to cardiovascular involvement based on the current evidence. COVID-19 remains a threat to global public health. The associated extra-pulmonary manifestations and their prolonged consequences are frequently overlooked. Pre-existing cardiovascular disease or acute cardiac complications may contribute to adverse early clinical outcome. At the moment, there is no specific treatment for COVID-19, but multiple randomized controlled trials (RCT) are being conducted. New supportive therapies are being evaluated with promising results.

    Search related documents:
    Co phrase search for related documents
    • abdominal pain and abnormal liver: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • abdominal pain and acute ards respiratory distress syndrome: 1, 2, 3, 4
    • abdominal pain and acute cardiac injury: 1, 2
    • abdominal pain and acute coronary syndrome: 1
    • abdominal pain and acute disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56
    • abdominal pain and acute injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33
    • abdominal pain and acute sars cov respiratory syndrome cov: 1, 2, 3, 4
    • abdominal pain and acute severe pneumonia: 1, 2, 3, 4, 5, 6, 7
    • abdominal pain and additional risk factor: 1
    • abdominal pain and lopinavir ritonavir: 1, 2, 3, 4
    • abdominal pain and low respiratory tract: 1
    • abdominal pain and lymphopenia leucopenia: 1
    • abnormal coagulation and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5
    • abnormal coagulation and acute cardiac injury: 1
    • abnormal coagulation and acute coronary syndrome: 1
    • abnormal coagulation and acute disease: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • abnormal coagulation and acute injury: 1, 2, 3, 4, 5, 6, 7
    • abnormal coagulation and acute severe pneumonia: 1
    • abnormal coagulation and lopinavir ritonavir: 1